NCT01461213: Gene Therapy for Blindness Caused by Choroideremia
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 14 taking part
- Started
- Oct 2011
- Primary completion
- Oct 2017
- Arms
- Dose 1, Dose 2
- Results
- None posted
- 28 Oct 2011: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.